Agomab Therapeutics NV (AGMB): SCHEDULE 13G filed May 15, 2026

Form type

SCHEDULE 13G

Filing date

May 15, 2026

Accession number

0001104659-26-062718

Filer

Agomab Therapeutics NV (CIK 2020932)